Related Experiment Videos
Isoniazid and antidepressants: is there cause for concern?
International Clinical Psychopharmacology
|January 1, 1994
Summary
Isoniazid, an antituberculosis drug, may interact with antidepressants. Caution is advised when combining these medications due to potential adverse events, especially for patients on monoamine oxidase inhibitors.
Area of Science:
- Pharmacology
- Clinical Medicine
- Drug Interactions
Background:
- Isoniazid is a primary antituberculosis medication.
- Isoniazid possesses weak monoamine oxidase inhibiting properties.
- Standard monoamine oxidase inhibitor (MAOI) precautions are not typically applied to isoniazid use.
Observation:
- Three cases of co-administration of isoniazid and antidepressant drugs were observed.
- Two of these cases involved adverse events potentially linked to drug interactions.
- These events highlight a possible interaction between isoniazid and antidepressants.
Findings:
- The combination of isoniazid and certain antidepressants may lead to adverse events.
- The monoamine oxidase inhibiting properties of isoniazid could contribute to these interactions.
- Further research is needed to fully understand the scope of this drug interaction.
Implications:
- Clinicians should exercise caution when prescribing isoniazid concurrently with antidepressant medications.
- Patients receiving this combination should be closely monitored for adverse effects.
- This finding suggests a need for updated guidelines regarding isoniazid co-administration with psychotropic drugs.